Bio-Rad Laboratories: EVP Evran Sedat exercised 1,044 shares

What happened

• Evran Sedat, EVP, global supply chain, had restricted stock units vest and converted into shares on Oct 20, 2026. The Form 4 shows 1,044 shares acquired at $0.00 and 487 shares disposed at $354.50 for $172,642 to satisfy tax withholding. The filing also lists a 1,044-share derivative conversion at $0.00.

Key details

• Transaction date(s) and price(s): Oct 20, 2026 — 1,044 shares acquired at $0.00 (code M); 487 shares disposed at $354.50 for $172,642 (tax withholding, code F); 1,044-share derivative conversion at $0.00 (code M, disposed).
• Shares owned after the transaction: not reported in this Form 4.
• Relevant footnotes: F1 — shares acquired on vesting of restricted stock units; F2 — each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock; F3 — on Oct 20, 2023 the reporting person was granted 4,176 restricted stock units vesting in four equal annual installments beginning on the first anniversary of the grant date.
• Filing date and timeliness: Form 4 filed Oct 22, 2026 reporting the Oct 20, 2026 transaction; the Form 4 does not indicate a late filing.

Why it may matter

• The transactions reflect vesting and conversion of RSUs, with 487 shares withheld to satisfy tax obligations (a sell-to-cover/cashless-style withholding), rather than the insider receiving all exercised shares in marketable form.
• The Form 4 shows an RSU vesting and related tax withholding; it does not show why the insider traded or why the company acted.